Concepedia

Yan Xia

YX

Statistics

Publications

13

Citations

318

H-Index

11

Active since

2006

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Xi'an Jiaotong University

Guangzhou University of Chinese Medicine

Yan Xia is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

MedicinePharmacologyDrug DiscoveryBiochemistryNatural SciencesMedicinal ChemistryThrombosisPharmacotherapyHematologyChemical Biology

Publications per year

2006–2025

13

Publications

13

Discovery of a nortropanol derivative as a potent and orally active GPR119 agonist for type 2 diabetes

Yan Xia, Samuel Chackalamannil, William J. Greenlee et al. · Bioorganic & Medicinal Chemistry Letters · 2011 · 43 citations · Full text

Diabetes Management, Biochemistry, Nortropanol Derivative +8

Metabolism-Based Identification of a Potent Thrombin Receptor Antagonist

Martin C. Clasby, Samuel Chackalamannil, Michael Czarniecki et al. · Journal of Medicinal Chemistry · 2006 · 39 citations · Full text

Metabolism-based Identification, Pharmacotherapy, Thrombosis +17

Heterotricyclic Himbacine Analogs as Potent, Orally Active Thrombin Receptor (Protease Activated Receptor-1) Antagonists

Mariappan V. Chelliah, Samuel Chackalamannil, Yan Xia et al. · Journal of Medicinal Chemistry · 2007 · 35 citations · Full text

Combinatorial Chemistry, Robust Inhibition, Pharmacotherapy +19

Discovery of MK-8831, A Novel Spiro-Proline Macrocycle as a Pan-Genotypic HCV-NS3/4a Protease Inhibitor

Santhosh Neelamkavil, Sony Agrawal, Thomas Bara et al. · ACS Medicinal Chemistry Letters · 2015 · 33 citations · Full text

Ns3/4a Protease Inhibitor, Drug Target, Molecular Biology +17

US Trends in Glycemic Control, Treatment, and Comorbidity Burden in Patients With Diabetes

Fadia T. Shaya, Yan Xia, Pei‐Jung Lin et al. · Journal of Clinical Hypertension · 2010 · 29 citations · Full text

1–5 of 13